These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 307989)

  • 21. Purification to electrophoretic homogeneity of human alpha lymphotoxin from a cloned continuous lymphoblastoid cell line IR 3.4.
    Johnson DL; Yamamoto RS; Plunkett JM; Masunaka IK; Granger GA
    Mol Immunol; 1983 Nov; 20(11):1241-4. PubMed ID: 6606757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic activity of lymphocytes. II. Studies on mechanism of lymphotoxin-mediated cytotoxicity.
    Walker SM; Lucas ZJ
    J Immunol; 1972 Dec; 109(6):1233-44. PubMed ID: 5086236
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
    Kramer SL; Granger GA
    J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro.
    Yamamoto RS; Hiserodt JC; Lewis JE; Carmack CE; Granger GA
    Cell Immunol; 1978 Jul; 38(2):403-16. PubMed ID: 79447
    [No Abstract]   [Full Text] [Related]  

  • 25. Further observations on the incidence and properties of lymphocytotoxins in leukaemia.
    Dickson A; Birchmore B
    Acta Haematol; 1977; 58(5):298-306. PubMed ID: 413306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of LT molecules with restricted physical heterogeneity by a continuous human lymphoid cell line in vitro.
    Fair DS; Jeffes EW; Granger GA
    Mol Immunol; 1979 Mar; 16(3):185-92. PubMed ID: 314928
    [No Abstract]   [Full Text] [Related]  

  • 27. The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro.
    Hiserodt JC; Yamamoto RS; Granger GA
    Cell Immunol; 1978 Dec; 41(2):380-96. PubMed ID: 83202
    [No Abstract]   [Full Text] [Related]  

  • 28. A physicochemical and immunologic comparison of the cell growth inhibitory activity of human lymphotoxins and interferons in vitro.
    Ware CF; Granger GA
    J Immunol; 1979 May; 122(5):1763-70. PubMed ID: 312850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
    Ware CF; Granger GA
    J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic activity of lymphocytes. VIII. Lymphotoxin activity in cell-free extracts of activated lymphocytes.
    Lee SC; Lucas ZJ
    Cell Immunol; 1979 Nov; 48(1):166-81. PubMed ID: 315829
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory substances produced by lymphocytes. II. Lymphotoxin in the rat.
    Namba Y; Waksman BH
    J Immunol; 1975 Oct; 115(4):1018-22. PubMed ID: 1080770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.
    Stone-Wolff DS; Yip YK; Kelker HC; Le J; Henriksen-Destefano D; Rubin BY; Rinderknecht E; Aggarwal BB; Vilcek J
    J Exp Med; 1984 Mar; 159(3):828-43. PubMed ID: 6421983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s).
    Yamamoto RS; Hiserodt JC; Granger GA
    Cell Immunol; 1979 Jul; 45(2):261-75. PubMed ID: 157226
    [No Abstract]   [Full Text] [Related]  

  • 34. Alteratons in RNA synthesis in lymphotoxin-treated target cells.
    Kunitomi G; Rosenau W; Burke GC; Goldberg ML
    Am J Pathol; 1975 Aug; 80(2):249-60. PubMed ID: 1080634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphotoxins: a multicomponent system of cell-lytic lymphocyte-released effector molecules.
    Granger GA; Yamamoto RS; Devlin JJ; Klostergaard J
    Lymphokine Res; 1982; 1(2):45-9. PubMed ID: 6985401
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of recombinant human lymphotoxin (tumor necrosis factor-beta) produced by a mammalian cell line.
    Hains JM; Aggarwal BB
    Arch Biochem Biophys; 1989 Nov; 274(2):417-25. PubMed ID: 2802619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guinea-pig lymphotoxin. Assay and physicochemical properties (author's transl)].
    Goguel AF; Nauciel C
    Ann Immunol (Paris); 1974 Jun; 125 C(4):569-79. PubMed ID: 4548830
    [No Abstract]   [Full Text] [Related]  

  • 39. Cellular origin of human lymphotoxin and its purification.
    Pichyangkul S; Miller JE; Waldrop S; Khan A
    Clin Immunol Immunopathol; 1985 Apr; 35(1):22-34. PubMed ID: 3873301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Size heterogeneity of human lymphotoxin is due to O-linked glycosylation.
    Kofler G; Göttfried I; Benjamin D; Tschachler E
    Lymphokine Cytokine Res; 1992 Feb; 11(1):9-14. PubMed ID: 1576249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.